| Chairman |
|
Chen Haoyang |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman & President: Chen Haoyang
Executive Director: Zhao Yongkai, Xu Xu, Lu Jizhong, Feng Yu
Independent Non-executive Director: Chan Hok Leung, Liu Shuang, Guo Wei.
|
| Principle Business |
|
The Group is principally engaged in the operation and management of hospitals in the PRC, with strategic focus on the provision of oncology healthcare services. |
| Related Indexes | | Hang Seng Composite Index | Hang Seng Healthcare Index | | Hang Seng Composite SmallCap Index | Hang Seng Healthcare Industry Index |
|
| Major Shareholders |
| Bayway Fund L.P. | 682,266,228 | 51.75% | 2025/06/23 | | Shanghai Zhenghesheng Enterprise Management Partnership (Limited Partnership) | 109,090,909 | 8.27% | 2025/06/23 | | Zhu Hongbing & Family | 95,915,590 | 7.27% | 2025/06/23 | | Shanghai Shengren Enterprise Management Partnership (Limited Partnership) | 90,666,667 | 6.88% | 2025/06/23 |
|
|
|
|